A year end message from the CEO – ATEL Capital Group – LEARN MORE

X

Home
Leasing
Private Debt
Properties
Securities
Investors
- Retail Investors
- Institutional Investors
Company
- Company
- Management
- Careers
- ATEL Foundation
- Contact
- COVID-19

Portfolio Companies

Adenosine Therapeutics, LLC

Adesto Technologies

ALBA Therapeutics

Altierre

Alveolus

Amyris

Apeel Sciences

Arbinet

Arcanum Alloys

Arsenal

Aryx Therapeutics

Asempra

Aspen Aerogels

Audience Science

Avogy

Axcient

Axial Biotech

AxoGen

Bloomenergy

Blue River

Boingo

Booster Fuels

Bowery

Cambrios

Cedar Point

Chelsio

Complete Genomics

Convio

CryoCor

Cymbet Corporation

CytomX

Danger, Inc.

Defense.net

Delivery Agent

Digital Ocean

Divergent 3D

Doppelganger

Dorado

Drawbridge

Ecoatm

Ecologic

EdeniQ

Emulate

Enerkem

Enevate

Enphase Energy

Five 9

Forma Therapeutics

GangaGen

Good

Hexagon Bio

Imergy

Infini Route Networks

Innova Light

InSite One

IntelePeer

Ioxus

Ipierian

Kabam

Kaminario

Katerra

Kinestral

Lightship Telecom

LimeBike

Linden Lab

Locus

LS9

Maculogix

Medgenome

Metabolon

Miasole

Microfabrica

Millennium Pharmacy Systems Inc.

Motosport

NanoGram Corporation

NexPlanar

On24

OpenPages

OpSource

Primet

QSr

Raydiance

Recyclebank

Renal Solutions

RenewData

Reply.com

Revolution Foods

Sensity

Silver POP

Sixtron

Skillz

SLDLaser

Sling Media

Solaria

SolFocus

Soraa

Starcite

Step Labs

Technorati

Tegile

Tele Pacific

Trilumina

True North Therapeutics

Twist Bioscience

Xiacato

xlumena

Zeevo

ATEL Capital Group

The Transamerica Pyramid

600 Montgomery St., 9th Floor

San Francisco, CA 94111

header title
header title
header title
- Retail Investors
- Institutional Investors
header title
header title
- Properties

Proud members of:

Equipment Leasing & Financial Association

National Venture Capital Association

Financial Industry Regulatory Authority

Copyright © 2021 ATEL Capital Group Site designed by Alexander Burton